PSTV
PSTV
NASDAQ · Biotechnology

Plus Therapeutics Inc

$0.26
+0.03 (+11.12%)
As of Feb 8, 2:19 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 35.79M 31.57M 32.41M
Net Income 827.5K 932.2K 975.1K
EPS
Profit Margin 2.3% 3.0% 3.0%
Rev Growth +6.8% +6.0% -3.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 13.26M 17.01M 14.45M
Total Equity 21.76M 23.46M 24.58M
D/E Ratio 0.61 0.73 0.59
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.82M 1.58M 1.77M
Free Cash Flow 629.7K 483.5K 562.4K